Orphan Drug Designation is an important development for any experimental drug and has been instigated in a number of territories including the U.S, Cantrixil was granted Orphan Drug Designation under the U.S. Orphan drug Act following a review by the FDA of a package of pre-clinical data submitted by the Company.
http://ift.tt/1OEecFn
No comments:
Post a Comment